Investing.com – IDEXX Labs (NASDAQ: ) reported second quarter EPS of $2.67, $0.19 better than the analyst estimate of $2.48. Revenue for the quarter came in at $944M versus the consensus estimate of $934.77M.
IDEXX Labs sees FY 2023 EPS of $9.64-$9.90 versus the analyst consensus of $9.69.
IDEXX Labs sees FY 2023 revenue of $3.66B-$3.72B versus the analyst consensus of $3.67B.
IDEXX Labs’s stock price closed at $554.73. It is up 18.15% in the last 3 months and up 39.05% in the last 12 months.
IDEXX Labs saw 2 positive EPS revisions and 8 negative EPS revisions in the last 90 days. See IDEXX Labs’s stock price’s past reactions to earnings here.
According to InvestingPro, IDEXX Labs’s Financial Health score is “great performance”.
Check out IDEXX Labs’s , and IDEXX Labs’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar